Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing

Genay Pilarowski, Carina Marquez, Luis Rubio, James Peng, Jackie Martinez, Douglas Black, Gabriel Chamie, Diane Jones, Jon Jacobo, Valerie Tulier-Laiwa, Susana Rojas, Susy Rojas, Chesa Cox, Maya Petersen, Joe DeRisi, Diane V Havlir

Clinical Infectious Diseases
December 26, 2020

This study was a field validation of BinaxNow rapid antigen testing, including among asymptomatic persons and children. These tests are now available over the counter.

Abstract: Among 3,302 persons tested for SARS-CoV-2 by BinaxNOW TM and RT-PCR in a community setting, rapid assay sensitivity was 100%/98.5%/89% using RT-PCR Ct thresholds of 30, 35 and none. The specificity was 99.9%. Performance was high across ages and those with and without symptoms. Rapid resulting permitted immediate public health action.

Featured Fellows

Maya Petersen

School of Public Health, UC Berkeley
Faculty Affiliate